GALC and Krabbe disease: While our substrate reduction approach complements the strategies of the publications highlighted above, it is important to put our results in the context of reports suggesting that modulation of the sphingolipid pathway that is perturbed by GALC deficiency could be efficacious in the setting of Krabbe disease.